Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (491-500 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|March 31, 1999
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarctionD Hasdai, A Lerman, C S Rihal, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
European Heart Journal|April 1, 1999
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary ArteriesD Hasdai, D R Holmes, E J Topol, et al.
Journal of the American College of Cardiology|November 18, 2000
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) TrialH C Herrmann, D J Moliterno, E M Ohman, et al.
Circulation|February 9, 1999
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI)K M Detre, P Guo, R Holubkov, et al.
The New England Journal of Medicine|March 16, 2000
Cost effectiveness of early discharge after uncomplicated acute myocardial infarctionL K Newby, E L Eisenstein, R M Califf, et al.
Circulation|February 22, 2001
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studiesG I Barbash, Y Birnbaum, K Bogaerts, et al.
Journal of Electrocardiology|February 25, 2000
The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: an AMISTAD substudy. Acute Myocardial Infarction Study AdenosineA Barbagelata, M F Di Carli, E B Sgarbossa, et al.
European Heart Journal|December 1, 2001
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAF Van de Werf, H V Barron, P W Armstrong, et al.
Circulation|March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.
Pageof 57

Showing results (491-500 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|March 31, 1999
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarctionD Hasdai, A Lerman, C S Rihal, et al.
American Heart Journal|January 5, 2000
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failureM S Cuffe, R M Califf, K F Adams, et al.
European Heart Journal|April 1, 1999
Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary ArteriesD Hasdai, D R Holmes, E J Topol, et al.
Journal of the American College of Cardiology|November 18, 2000
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) TrialH C Herrmann, D J Moliterno, E M Ohman, et al.
Circulation|February 9, 1999
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI)K M Detre, P Guo, R Holubkov, et al.
The New England Journal of Medicine|March 16, 2000
Cost effectiveness of early discharge after uncomplicated acute myocardial infarctionL K Newby, E L Eisenstein, R M Califf, et al.
Circulation|February 22, 2001
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studiesG I Barbash, Y Birnbaum, K Bogaerts, et al.
Journal of Electrocardiology|February 25, 2000
The use of tomographic myocardial perfusion scanning to evaluate an electrocardiographic salvage estimation method in patients with acute myocardial infarction: an AMISTAD substudy. Acute Myocardial Infarction Study AdenosineA Barbagelata, M F Di Carli, E B Sgarbossa, et al.
European Heart Journal|December 1, 2001
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PAF Van de Werf, H V Barron, P W Armstrong, et al.
Circulation|March 7, 1998
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic InvestigatorsS G Goodman, A Langer, A M Ross, et al.
Pageof 57